NCT06686550

Brief Summary

The investigators are going to conduct a prospective observational cohort study in pediatric patients aged 28 days to 14 years old scheduled for elective cardiac surgery with cardiopulmonary bypass. The primary purpose of this study is to explore the effect of preoperative sleep disturbance on the incidence of postoperative delirium. Sleep status will be assessed using the Brief Infant Sleep Questionnaire(BISQ) and Children's Sleep Habits Questionnaire (CSHQ), and postoperative delirium status will be evaluated by Cornell assessment of pediatric delirium(CAPD). During the peri-operative period, children will wear actigraphs to record their sleep parameters.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
435

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Nov 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Nov 2024Jun 2026

First Submitted

Initial submission to the registry

October 31, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

November 10, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 13, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Expected
Last Updated

November 13, 2024

Status Verified

November 1, 2024

Enrollment Period

1 year

First QC Date

October 31, 2024

Last Update Submit

November 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of postoperative delirium

    Postoperative 7 days

Secondary Outcomes (8)

  • The proportions of subtypes of postoperative delirium( hypoactive, hyperactive, and mixed).

    Postoperative 7 days

  • Pain defined by the Face, Legs, Activity, Cry, and Consolability scale

    Postoperative 7 days

  • The incidence of postoperative Acute kidney injury

    Within postoperative 7 days.

  • Pulmonary complication

    Postoperative 7 days

  • The incidence of postoperative Liver dysfunction

    Postoperative 7 days

  • +3 more secondary outcomes

Other Outcomes (4)

  • Concentration of plasma intestinal injury markers

    Before surgery and 24 hours after surgery

  • Concentration of plasma blood-brain barrier injury markers

    Before surgery and 24 hours after surgery

  • Concentration of plasma inflammatory factors.

    Before surgery and 24 hours after surgery

  • +1 more other outcomes

Study Arms (1)

Children scheduled to undergo elective congenital heart disease repair surgery with CPB

Other: This is a observational study and there is no intervention.

Interventions

This is a observational study and there is no intervention.

Children scheduled to undergo elective congenital heart disease repair surgery with CPB

Eligibility Criteria

Age28 Days - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Pediatric patients aged more than 28 days and less than 14 years old who are scheduled to undergo elective corrective surgery for congenital heart disease under cardiopulmonary bypass.

You may qualify if:

  • Aged more than 28 days and less than 14 years old;
  • Scheduled to undergo elective corrective surgery for congenital heart disease under cardiopulmonary bypass.

You may not qualify if:

  • Emergency surgery;
  • Combined with severe hepatic and renal dysfunction (with a diagnosis of acute or chronic renal insufficiency or requiring renal replacement therapy; with a diagnosis of acute or chronic hepatic insufficiency or requiring artificial liver treatment);
  • Combined with non-cardiac malformations (adenoidal hypertrophy, tracheobronchial stenosis and ocular disorders);
  • History of preoperative cerebral ischemia or haemorrhage;
  • Refuse to sign the informed consent form or the child has poor compliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma

MeSH Terms

Conditions

Emergence DeliriumParasomniasHeart Defects, Congenital

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental DisordersSleep Wake DisordersCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chinese Academy of Medical Sciences, Fuwai Hospital

Study Record Dates

First Submitted

October 31, 2024

First Posted

November 13, 2024

Study Start

November 10, 2024

Primary Completion

November 10, 2025

Study Completion (Estimated)

June 15, 2026

Last Updated

November 13, 2024

Record last verified: 2024-11